Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96ecb788072c4ea29f9c14e7e96dcf15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:96ecb788072c4ea29f9c14e7e96dcf15 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:96ecb788072c4ea29f9c14e7e96dcf152021-11-25T18:40:57ZInhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design10.3390/pharmaceutics131118251999-4923https://doaj.org/article/96ecb788072c4ea29f9c14e7e96dcf152021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1825https://doaj.org/toc/1999-4923Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs. Mannitol was selected as water soluble matrix excipient for constructing respirable dry microparticles by spray drying technique. A Quality by Design approach was applied for understanding the effect of the feed composition and spraying feed rate on typical quality attributes of inhalation powders. The in vitro aerodynamic behaviour of powders was evaluated using a medium resistance device. The inner structure and morphology of generated microparticles were also studied. The 1:4 ratio of CaPs/mannitol led to the generation of hollow microparticles, with the best aerodynamic performance. After microparticle dissolution, the released nanoparticles kept their original size.Eride QuartaFabio SonvicoRuggero BettiniClaudio De LucaAlessandro DottiDaniele CatalucciMichele IafiscoLorenzo Degli EspostiGaia ColomboGiovanna TrevisiDimitrios M. RekkasAlessandra RossiTin Wui WongFrancesca ButtiniPaolo ColomboMDPI AGarticlecalcium phosphate nanoparticlesmicroparticles embedding nanoparticlesdesign of experimentpulmonary deliveryPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1825, p 1825 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
calcium phosphate nanoparticles microparticles embedding nanoparticles design of experiment pulmonary delivery Pharmacy and materia medica RS1-441 |
spellingShingle |
calcium phosphate nanoparticles microparticles embedding nanoparticles design of experiment pulmonary delivery Pharmacy and materia medica RS1-441 Eride Quarta Fabio Sonvico Ruggero Bettini Claudio De Luca Alessandro Dotti Daniele Catalucci Michele Iafisco Lorenzo Degli Esposti Gaia Colombo Giovanna Trevisi Dimitrios M. Rekkas Alessandra Rossi Tin Wui Wong Francesca Buttini Paolo Colombo Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design |
description |
Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs. Mannitol was selected as water soluble matrix excipient for constructing respirable dry microparticles by spray drying technique. A Quality by Design approach was applied for understanding the effect of the feed composition and spraying feed rate on typical quality attributes of inhalation powders. The in vitro aerodynamic behaviour of powders was evaluated using a medium resistance device. The inner structure and morphology of generated microparticles were also studied. The 1:4 ratio of CaPs/mannitol led to the generation of hollow microparticles, with the best aerodynamic performance. After microparticle dissolution, the released nanoparticles kept their original size. |
format |
article |
author |
Eride Quarta Fabio Sonvico Ruggero Bettini Claudio De Luca Alessandro Dotti Daniele Catalucci Michele Iafisco Lorenzo Degli Esposti Gaia Colombo Giovanna Trevisi Dimitrios M. Rekkas Alessandra Rossi Tin Wui Wong Francesca Buttini Paolo Colombo |
author_facet |
Eride Quarta Fabio Sonvico Ruggero Bettini Claudio De Luca Alessandro Dotti Daniele Catalucci Michele Iafisco Lorenzo Degli Esposti Gaia Colombo Giovanna Trevisi Dimitrios M. Rekkas Alessandra Rossi Tin Wui Wong Francesca Buttini Paolo Colombo |
author_sort |
Eride Quarta |
title |
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design |
title_short |
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design |
title_full |
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design |
title_fullStr |
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design |
title_full_unstemmed |
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design |
title_sort |
inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: the formulation experimental design |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/96ecb788072c4ea29f9c14e7e96dcf15 |
work_keys_str_mv |
AT eridequarta inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT fabiosonvico inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT ruggerobettini inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT claudiodeluca inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT alessandrodotti inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT danielecatalucci inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT micheleiafisco inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT lorenzodegliesposti inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT gaiacolombo inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT giovannatrevisi inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT dimitriosmrekkas inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT alessandrarossi inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT tinwuiwong inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT francescabuttini inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign AT paolocolombo inhalablemicroparticlesembeddingcalciumphosphatenanoparticlesforhearttargetingtheformulationexperimentaldesign |
_version_ |
1718410850173190144 |